Xconomy National

Archives

by in

Entry	Author	Date	Location
AvidBiotics Sees New Angle for Personalized Medicine in Antibiotics	Luke Timmerman	02/01/12	San Francisco
Four Themes to Watch in Personalized Medicine	Jonathan Sheffi	01/30/12	San Francisco
From AI to Bioengineering	Sebastian Thrun	01/18/12	San Francisco
Ann Arbor’s Everist Genomics Develops New Tests for Cancer Risk	Sarah Schmid	12/14/11	Detroit
Buyouts, Quantified Health, & More San Diego Life Sciences News	Bruce V. Bigelow	12/01/11	San Diego
The Herman Cain-Inspired “1-100-0″ Plan for Personalized Medicine?	Luke Timmerman	11/14/11	National
Come Get Coffee With Xconomy at Our Tuesday Meetup. And GI Alumni, Bring Your Swag	Luke Timmerman	11/04/11	Boston
The Cancer Drug Dark Ages Are Coming to an End	Luke Timmerman	10/31/11	National
23andMe Identifies Possible Protective Gene Against Parkinson’s Disease	Bruce V. Bigelow	10/25/11	San Diego
Life Sciences 2031: What about 2011?	David Sable	10/20/11	New York
Cleave Biosciences Nabs $42M, Veteran Execs, to Chase Personalized Cancer Therapies	Luke Timmerman	10/11/11	San Francisco
Thane Kreiner, the Biotech-Entrepreneur-Turned-Educator With 1 Billion People on His Mind	Luke Timmerman	08/25/11	San Francisco
Stéphane Bancel, Former bioMérieux CEO, Talks Future of Startups, Diagnostics, Pharma	Gregory T. Huang	08/04/11	Boston
Innovation at Large Scale: A Glimpse of this Thursday’s XSITE Keynote by Intellectual Ventures’ Edward Jung	Robert Buderi	06/14/11	Boston
Zacharon Aligns with Pfizer, Conatus Raises Big Bucks, Software Veteran Wins Wireless Institute Challenge, & More San Diego Life Sciences News	Bruce V. Bigelow	04/14/11	San Diego
Blueprint Medicines Brings In $40M, Led by Third Rock, for Targeted Cancer Therapies	Gregory T. Huang	04/11/11	Boston
Will the Bay Area Still Be the No. 1 Biotech Cluster in 20 Years? We’ll Ask Tomorrow	Luke Timmerman	03/15/11	San Francisco
Genomic Health, Taking a Hit on Bottom Line, Bets Next-Gen Sequencing Will Yield Next-Gen Diagnostics	Luke Timmerman	02/15/11	San Francisco
Adriana Jenkins, Boston Biotech PR Maven, Dies from Breast Cancer at 41	Luke Timmerman	02/10/11	Boston
See You This Afternoon at “Computing in the Age of the $1,000 Genome”	Luke Timmerman	02/07/11	Seattle
Diagnostics Are Warming Up in Era of Fast, Cheap Sequencing, Says MDV’s Rowan Chapman	Luke Timmerman	02/07/11	San Francisco
California Biotech To Add Jobs, Merck’s Bet on Biotech Drugs in Palo Alto, & More Bay Area Life Sciences News	Luke Timmerman	02/04/11	San Francisco
Seattle Genetics Reloads, Uptake Ups and Leaves, PhysioSonics Raises Cash, & More Seattle-Area Life Sciences News	Luke Timmerman	02/03/11	Seattle
Personalized Medicine Regulation Needs More Than Band-Aids	Daniel Vorhaus	01/28/11	National
The 20-Year Outlook for Bay Area Life Sciences, Coming March 16	Luke Timmerman	01/25/11	San Francisco
Internet Commerce Pioneer Seeks to Crack Secretive Culture With Cancer Commons	Luke Timmerman	01/04/11	San Francisco
In Talk on Personalized Medicine, Life Technologies’ CEO Explains Shift in Corporate Strategy	Bruce V. Bigelow	10/26/10	San Diego
Sage Attracts Bigwigs, Hutch Adds Immunotherapy Center, the Pro-Life Vaccine Firm, & More Seattle-Area Life Sciences News	Luke Timmerman	10/07/10	Seattle
Necessity is the Mother of Stratification: Personalized Medicine is Getting Real	Don Rule	09/30/10	Seattle
NextBio Finds Profit at Intersection Between Public and Private Genomic Data	Luke Timmerman	09/28/10	San Francisco
Page 1 of 3	next page »